Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp).

BMC Health Serv Res · 2025 · PMC11883968 · PMID 40045306

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Results from the KARISMA Endoxifen indicate an even higher usage rate (97.1%), demonstrating a positive trend also for more complex tasks to be performed using the app ( Table 9 ).

also in 6,846 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.